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A B S T R A C T
Cytinus hypocistis whole plant and its three different parts (petals, stalks, and nectar) were chemically char-
acterised and their biological properties evaluated. A total of 17 phenolic compounds were identified, being
galloyl-bis-HHDP-glucose the most abundant. All the tested extracts showed high antioxidant capacity, with the
petals exhibiting the most promising results both in the OxHLIA (IC50 = 0.279 ng/mL) and TBARS
(IC50 = 0.342 ng/mL) assays. For the antidiabetic and anti-tyrosinase enzyme inhibitory assays, the stalk extract
presented the lowest IC50 values, 0.039 mg/mL and 0.09 mg/mL, respectively. Regarding antibacterial activity,
all tested extracts displayed broad-spectrum microbial inhibition against both Gram-positive and Gram-negative
bacteria. Similarly, all extracts displayed effective anti-proliferation activity against four tested tumour cell lines
(NCI–H460, HeLa, HepG2, and MCF-7), with no toxicity observed for a non-tumour cell line. Considering the
anti-inflammatory activity, the petals showed the highest nitric oxide inhibition (IC50 = 127 μg/mL). These
results point C. hypocistis as a promising source of health-promoting biomolecules.
1. Introduction
Medicinal plants have been used as medicine by humans for thou-
sands of years in the form of crude drugs such as teas, tinctures,
poultices, and later through more sophisticated techniques as com-
pound isolation (Balunas and Kinghorn, 2005). After a period of in-
difference, in which synthetic compounds were preferred, there is an
increasing interest in studying the active principles behind plants
therapeutic properties (Graça et al., 2016). The pharmaceutical in-
dustry faces unprecedented challenges, with fewer compounds being
found, tested, and released to the public mainly due to the several
drawbacks of the process to approve new drugs, humans have once
again turned to Nature to mitigate the relative void of combinatorial
chemistry to find new compounds (Phillipson, 2007).
Polyphenols are the largest and the most widespread group of sec-
ondary metabolites in plants. With a great variety of structures, ranging
from simple compounds with few aromatic rings to highly polymeric
substances, such as flavonoids, stilbenes, lignans, and phenolic acids.
These compounds are commonly found in both edible and inedible
plants, and have been reported to have multiple biological effects
(Okuda and Ito, 2011). Tannins, being one of the most structurally
diverse polyphenols, have been reported to play a crucial role in plant
defence against pathogens, herbivores and climatic changes. Structu-
rally, tannins can be subdivided into two major groups: condensed
tannins (or proanthocyanidins), which are of flavonoid origin, and
hydrolysable tannins, which are defined as esters of gallic acid with a
polyol moiety, mainly β-D-glucose (Petersen et al., 2010). The last
group can be further subdivided into gallotannins and ellagitannins,
and their basic building block is β-glucogallin (1-O-galloyl-β-D gluco-
pyranose) (Petersen et al., 2010). Typical complex gallotannins are the
addition of gallic acid moieties and the formation of depsidic meta-
bonds between suitably positioned galloyl residues in the molecule.
Ellagitannins, however, are derived from pentagalloylglucose through
an oxidative linkage of the galloyl moieties, leading to the formation of
3,4,5,3′,4′,5′-hexahydroxydiphenoyl (HHDP) moieties; they are named
after their characteristic hydrolysis product, ellagic acid, the dilactone
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of HHDP. Whereas gallotannins seem to be mainly restricted to woody
dicotyledonous plants, ellagitannins are more widely spread in the
plant kingdom (Petersen et al., 2010).
Cytinus hypocistis (L.) L. (Cytinaceae family) is an endophytic para-
sitic plant on various members of the Cistaceae family occurring in the
Mediterranean region. Apart from used as famine food, it was also
applied in a wide variety of traditional healthcare practices, including
dysentery, tumour of the throat, and eye inflammation treatment
(Zucca et al., 2015). Although its biological properties were potentially
attributed to its hydrolysable tannin content, to the authors' best
knowledge, it's chemical composition is largely unknown, and active
biomolecules are not yet identified (Magiatis et al., 2001; Zucca et al.,
2015). Therefore, the present work aims at chemically characterise C.
hypocistis and evaluate its antioxidant, antibacterial, anti-tyrosinase,
antidiabetic, anti-inflammatory and anti-proliferative properties.
2. Materials and methods
2.1. Standards and reagents
α-Glucosidase from Saccharomyces cerevisiae, trichloroacetic acid,
mushroom tyrosinase, sulforhodamine B, ellipticine, dexamethasone,
trypan blue, lipopolysaccharide (LPS), Tris(hydroxymethyl)amino-
methane, thiobarbituric acid (TBA), 2,2′-azobis(2-amidinopropane)di-
hydrochloride (AAPH), 3,4-dihydroxy-L-phenylalanine (L-DOPA), and
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) were
acquired from Sigma Chemical Co. (Saint Louis, MO, USA). p-
Iodonitrotetrazolium chloride (INT) was acquired from PanReac
AppliChem (Barcelona, Spain), and Tryptic Soy Broth (TSB) and
Mueller-Hinton (MHB) from Biolab® (Hungary). Dulbecco's Modified
Eagle's and RPMI-1640 mediums, fetal bovine serum (FBS), Hank's
balanced salt solution (HBSS), L-glutamine, nonessential amino acid
solution (2 mM), penicillin/streptomycin solutions, trypsin, and EDTA
were acquired from Hyclone (Logan, USA). Acetonitrile 99.9%, of High
Performance Liquid Chromatography (HPLC) grade, and dimethyl
sulfoxide (DMSO) were acquired from Fisher Scientific (Lisbon,
Portugal) and formic acid from PanReac (Barcelona, Spain). Phenolic
compound standards (catechin, gallic acid, and ellagic acid) were
purchased from Extrasynthese (Genay, France). All other chemicals
were of analytical grade and purchased from common sources. Water
was treated by means of a Milli-Q water purification system (TGI Pure
Water Systems, Greenville, SC, USA).
2.2. Sampling and extracts preparation
Cytinus hypocistis (L.) L. subsp. macranthus Wettst plants were col-
lected in July 2018 from the host species Halimium lasianthum subsp.
alyssoides (Lam.) Greuter at three different locations in Castro Daire,
Portugal. Plant identification, characterization, and preparation were
conducted as previously described by Silva et al. (2019). Fig. 1-A shows
how lyophilised plants were separated into four different samples,
whole plant (CH), petals (PCH), stalks (SCH) and nectar (NCH). Hy-
droethanolic extracts were then prepared as described by Bessada et al.
(2016) using ethanol/water (80:20, v/v) as extraction solvent.
2.3. Phenolic profile characterization
Phenolic compounds were determined by HPLC-DAD-ESI/MSn
(Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA) as
previously described (Bessada et al., 2016). Detection was carried out
with a DAD using 280 nm, 330 nm, and 370 nm as the preferred wa-
velengths and a mass spectrometer connected to the HPLC system. Mass
spectrometric detection was performed by means of a Linear Ion Trap
LTQ XL (Thermo Finnigan, San Jose, CA, USA) equipped with an ESI
source and spectrums were recorded in negative ion mode (m/z
100–1700). The phenolic compounds were characterized according to
their UV spectra, fragmentation pattern, their retention times, and
comparison with available standards. For quantification, calibration
curves were obtained from commercial standards: gallic acid
(y = 131538x + 292163; R2 = 0.9998; LOD = 0.68 μg/mL;
LOQ = 1.61 μg/mL); catechin (y = 84950x + 23200; R2 = 0.9999;
LOD = 0.17 μg/mL; LOQ = 0.68 μg/mL); ellagic acid (y = 26719x -
317255; R2 = 0.9996; LOD = 0.10 μg/mL; LOQ = 0.48 μg/mL). The
results were expressed in mg/g of extract.
2.4. Evaluation of bioactive properties
2.4.1. Antioxidant activity
The oxidative haemolysis (OxHLIA) and thiobarbituric acid reactive
substances (TBARS) formation inhibition assays were performed fol-
lowing methodologies previously described by Lockowandt et al.
(2019). Trolox was used as positive control.
OxHLIA assay. In a flat bottom 48-well microplate, 200 μL of ery-
throcytes in PBS (2.8% w/v) were mixed with 400 μL of the extract
samples (0.0625–2 μg/mL in PBS); PBS was used as control and milli-Q
water for complete haemolysis. After pre-incubation at 37 °C for 10 min
with shaking, AAPH (200 μL, 160 mM in PBS) was added and the op-
tical density (690 nm) was measured every ~10 min in a microplate
reader (Bio-Tek Instruments, ELX800) until complete haemolysis. The
results were given as IC50 values, i.e., extract concentration (ng/mL)
required to protect 50% of the erythrocyte population from the oxida-
tive haemolysis for Δt of 60 min and 120 min.
TBARS assay. The brains were obtained from pig (Sus scrofa) of body
weight ~147 Kg, dissected and homogenized with a polytron in ice-cold
Tris–HCl buffer (20 mM, pH 7.4) to produce a 1:2 (w/v) brain tissue
homogenate which was centrifuged at 3000 g for 10 min. The porcine
brain supernatant (1:2, w/v; 0.1 mL) was incubated with the extract
samples (0.0625–2 μg/mL in water; 0.2 mL) plus FeSO4 (10 μM; 0.1 mL)
and ascorbic acid (0.1 mM; 0.1 mL) at 37 °C for 1 h. Then, tri-
chloroacetic (28% w/v, 0.5 mL) and thiobarbituric (TBA, 2%, w/v,
0.38 mL) acids were added and the mixture was heated at 80 °C for
20 min. After centrifugation at 3000g for 10 min, the malondialdehyde
(MDA)-TBA complexes formed in the supernatant were monitored at
532 nm (Specord 200 spectrophotometer, Analytik Jena, Jena,
Germany). The results were given as IC50 values, i.e., extract con-
centration (ng/mL) providing 50% of antioxidant activity.
2.4.2. Antibacterial activity
The extracts were tested against microbial strains isolated from
different patients hospitalized at the Hospital Center of Trás-os-Montes
and Alto Douro (Vila Real, Portugal). Five Gram-negative bacteria
(Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas
aeruginosa and Morganella morganii) and four Gram-positive bacteria
(Enterococcus faecalis, Listeria monocytogenes, methicillin-sensitive
Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus
aureus) were incubated at 37 °C (24 h) in appropriate fresh medium
before further analysis. Minimum inhibitory concentration (MIC) was
performed by the microdilution method and the rapid p-iodonitrote-
trazolium chloride (INT) colorimetric assay, following the methodology
previously described by Pires et al. (2018). To each well (96-well mi-
croplate) containing a mixture of 190 μL of MHB/TSB and 10 μL of
bacteria inoculum (standardized at 1.5 × 106 CFU/mL), 200 μL of each
diluted extract concentration (20–0.15 mg/mL in 5% (v/v) DMSO/
MHB) were added. The lowest extract concentration that prevented
colour change (yellow to pink) by inhibiting bacterial growth is de-
scribed as MIC. Three negative controls were prepared, one with
Mueller-Hinton Broth (MHB), another with the extract, and the third
one with medium and antibiotic. For the Gram-negative bacteria, an-
tibiotics, such as ampicillin (20 mg/mL) and imipenem (1 mg/mL) were
used as positive controls, while ampicillin and vancomycin (1 mg/mL)
were used for the Gram-positive bacteria. The microplates were covered
and incubated at 37 °C for 24 h. MIC was detected adding 40 μL
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(0.2 mg/mL) of p-iodonitrotetrazolium chloride (INT) and incubation
the mixture at 37 °C for 30 min. For minimum bactericidal concentra-
tion (MBC) determination, 50 μL of the different well mixtures (no
colour change) were plated on solid medium and incubated at 37 °C for
24 h. The lowest concentration showing no bacteria growth was defined
as MBC.
2.4.3. Antidiabetic (glucosidase inhibitory) assay
The α-glycosidase inhibitory assay was adapted from the metho-
dology previously described by Les et al. (2017) and Spínola and
Castilho (2017). The assay was conducted in a 96-well microplate with
a reaction mixture containing 50 μL of extract sample diluted in 50 μL
of 100 mM-phosphate buffer (pH 6.8) and 50 μL yeast α-glucosidase (2
U/mL in same buffer). The reaction mixture was then incubated for
10 min, followed by addition of 50 μL substrate (5 mM, p-nitrophenyl-
α-D-glucopyranoside prepared in the same buffer). After 20 min of in-
cubation, the release of p-nitrophenol was spectrophotometrically
measured at 405 nm. Individual blanks and a positive control (acar-
bose) were prepared. The results were expressed as IC50 values (mg/
mL), which were calculated from the inhibition percentage values
achieved using the formula: Inhibition (%) = [(Abscontrol -Abssample)/
Abscontrol ]x100.
2.4.4. Tyrosinase inhibitory activity
Tyrosinase inhibitory activity of the extracts was determined as
previously described by Chen et al. (2009), using a SPECTROstar Nano
Multi-Detection Microplate Reader and 96-well plates (BMG Labtech,
Ortenberg, Germany). Each extract sample was dissolved in a mixture
of water and DMSO (5%). Four wells were attributed to each sample:
(A) 120 μL of 66 mM PBS (pH 6.8) and 40 μL of mushroom tyrosinase in
PBS (46 U/mL); (B) 160 μL PBS; (C) 80 μL PBS, 40 μL tyrosinase and
40 μL sample; (D) 120 μL PBS and 40 μL sample extract. After in-
cubation (10 min at room temperature), 40 μL of 2.5 mM L-DOPA
dissolved in PBS were added to each well, and the mixtures incubated at
room temperature for 20 min. The absorbance of each well was mea-
sured at 475 nm, and the inhibition percentage of the tyrosinase ac-
tivity was calculated using the equation: Inhibition (%)=((A-B)-(C-D))/
((A-B)) x 100. Kojic acid (0.10 mg/mL) was used as positive control.
IC50 values (mg/mL) were then calculated from the obtained inhibition
percentage values.
2.4.5. Anti-proliferative and hepatotoxic activity
Cell lines were obtained from ECACC: European Collection of
Animal Cell Culture (Salisbury, UK). MCF-7 (breast adenocarcinoma),
NCI–H460 (non-small cell lung carcinoma), HeLa (cervical carcinoma)
and HepG2 (hepatocellular carcinoma) were the tested human tumour
cell lines, and the cell density determination was performed using a
sulforhodamine B assay previously described by Guimarães et al.
(2013), where the amount of pigmented cells is directly proportional to
the total protein mass and, therefore, to the number of bounded cells.
These cell lines were treated with different concentrations
(0.125–0.4 mg/mL) of the extract samples dissolved in ultrapure water.
For the non-tumour cells, a cell culture previously prepared from a
freshly harvested porcine liver obtained from a local slaughter house as
described (Guimarães et al., 2013), and named as PLP2, was used to
determine hepatotoxicity (Guimarães et al., 2013). A phase-contrast
microscope was used to monitor the growth of the cell cultures. The
cells were sub-cultured and plated in 96-well plates (density of
1.0 × 104 cells/well). Dulbecco's modified eagle's medium (DMEM)
was used, with 10% of fetal bovine serum (FBS), 100 U/mL of peni-
cillin, and 100 μg/mL of streptomycin. Ellipticine was used as positive
control and the results were expressed as GI50 values (sample con-
centration in μg/mL that inhibited 50% of the net cell growth).
2.4.6. Anti-inflammatory activity
The concentration of nitrite produced by lipopolysaccharide (LPS)-
Fig. 1. A: Graphical representation of the four different studied parts of C. hypocistis; and B: Phenolic profile of C. hypocistis petals extract (PCH) recorded at 280 nm.
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stimulation was tested in a murine macrophages RAW 264.7 cell line
[ECACC: European Collection of Animal Cell Culture (Salisbury, UK)].
Cells were treated with different concentrations (0.125–0.4 mg/mL) of
the extract samples dissolved in ultrapure water, and the production of
nitric oxide (NO) was measured using the Griess Reagent System kit
Promega (Madison WI, USA) as formerly described by Souilem et al.
(2017). Dexamethasone (50 μM) was used as a positive control. The
results were expressed as IC50 values (μg/mL), corresponding to the
extract concentration providing a 50% inhibition in NO production.
2.5. Statistical analysis
Three samples were analyzed and all the assays were carried out in
triplicate. The results were expressed as mean values ± standard de-
viation (SD). Statistical analysis was conducted with the aid of SPSS v.
23.0 (IBM Corp., Armonk, NY, USA). Data were evaluated by a variance
analysis (ANOVA) and by a Tukey's HSD test (α = 0.05). The fulfilment
of the ANOVA requirements, specifically the normal distribution of
residuals and the homogeneity of variance, was tested by means of the
Shapiro Wilk's and Levene's tests, respectively. For comparison between
two samples, a two-tailed paired Student's t-test was applied to assess
statistical differences (α = 0.05).
3. Results and discussion
3.1. Composition of phenolic compounds
An exemplary phenolic profile of the C. hypocistis petals recorded at
280 nm is shown in Fig. 1-B, peak characteristics and tentative iden-
tities are presented in Table 1 and quantification is present in Table 2.
Compounds 1–3 and 5–17 showed a UV spectra coherent with hydro-
lysable tannins, ant its galloyl and hexahydroxydiphenoyl (HHDP) de-
rivatives. According to the literature, the main characteristics in the
mass spectra of these compounds are the losses of a proton [M-H]-, one
or more ellagic acid (302 mu), gallic acid (170 mu), and/or galloyl
groups (152 mu) (Carocho et al., 2014). Compounds number 1 and 2
were tentatively identified as galloyl-glucose and digalloyl-glucose,
respectively, due to the loss of a galloyl moiety characterized by a ty-
pical MS2 fragment at m/z 331. Elimination of a glucose moiety [162
mu] and subsequently formation of a deprotonated gallic acid at m/z
169 were also observed. The deprotonated gallic acid underwent dec-
arboxylation with mass loss of 44 to form a trihydroxyphenol moiety at
m/z 125 (Tan et al., 2011). Compounds number 3 and 5 were tenta-
tively deduced as trigalloyl-glucose, with [M-H]- at m/z 635, and a
typical MS2 fragment at m/z 483, indicating the loss of one galloyl
group (152 mu). Product ions at m/z 465 and 313, usually found on the
fragmentation scheme of gallotannins, were also observed (Mena et al.,
2012; Tan et al., 2011). Compound number 6 ([M-H]- at m/z 937;
fragment ions at m/z 767, 637, 467 and 301) was coherent with tri-
galloyl-HHDP-glucose isomers (Carocho et al., 2014). Compound
number 7 (tetragalloyl-glucoside; m/z 787) presented a characteristic
MS2 fragment at m/z 635 (trigalloyl-glucose), correspondent to the loss
of one galloyl group (152 mu), and product ions at m/z of 617 and 465,
consistent with the loss of a m/z 170 gallate moiety, H2O m/z 18 and
galloyl m/z 152, respectively (Owen et al., 2003). Compound number 8
presented a singly-charged pseudo-molecular ion [M-H]- at m/z 783
and together with daughter ions at m/z 765, 597, and 301 allowed its
identification as pedunculagin (i.e., bis-HHDP-glucose) isomers (Calani
et al., 2013; Sentandreu et al., 2013). The UV spectra of Compound
number 9 shows a precursor ion at m/z 939 and product ions at m/z 787
and 769, attributed to the loss of a galloyl group [M - 152 - H]- and a
water molecule [M - 152 - 18 - H]-, respectively. This ion fragment (m/z
769) underwent then the loss of a galloyl and a water molecule, ori-
ginating m/z fragments of 617 and 599, respectively. Although with the
absence of two MS2 fragments (m/z at 617 and 599) present in the UV
spectra of compound number 9, compound number 11 was also Ta
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identified as pentagalloyl-glucose (m/z 939) due to characteristic pro-
duct ions at m/z 787, 769, and 465, which unveil the presence of
homologous series of galloylglucose (Mena et al., 2012; Wyrepkowski
et al., 2014). Compound number 10 and 12 ([M-H]- at m/z 935) pre-
sented the same pseudomolecular ion and MS2 product ions at m/z 783,
765, 633, and 301, likely due to the loss of a water molecule, HHDP,
and galloyl-glucose moieties, respectively, thus being consistent with
galloyl-bis-HHDP-glucose isomers (Carocho et al., 2014). The fragment
ions at m/z 1087, 935, and 783 present in the UV spectra of compounds
number 13–17, show the consecutive loss of two galloyl moieties; that,
together with pseudomolecular ions at 1087 and 1259 m/z allowed its
identification as digalloyl-bis-HHDP-glucopyranose and trigalloyl-bis-
HHDP-glucopyranose (Hofmann et al., 2016; Liberal et al., 2015;
Salminen et al., 1999).
Regarding falvan-3-ols, (+)-catechin (compound number 4: [M-H]-
at m/z 289) was the only detected compound, being identified based on
the characteristic MS2 fragments at m/z 245 (loss of CO2), and 203
(cleavage of the A-ring of flavan-3-ol) (Carocho et al., 2014).
Although at different concentrations, seventeen phenolic com-
pounds were identified in all the four studied samples, being PCH the
sample exhibiting higher concentrations of compounds, followed by
CH, being galloyl-bis-HHDP-glucose the main compound in all the
samples. NCH was the sample with the lowest levels of phenolic com-
pounds (Table 2).
The most prevalent biological and pharmacological properties re-
ported for tannins on a molecular basis are superoxide anion scaven-
ging, apoptosis, antitumor, anti-EVB, anti-MRSA, and anti-plasmin in-
hibition, which are attributed to its strong capacity to bind to proteins,
large molecular compounds, and metallic ions. Galloyl moieties have
been identified as the most bioactive components of tannin-rich plants,
playing multiple functional roles such as antimicrobial, anti-in-
flammatory, antidiabetic, and antioxidant activities (Maisetta et al.,
2019). Besides, its excellent antioxidant capacity is associated with
chelation potency, which is mainly attributed to its catechol or galloyl
moieties present on the B ring of its structure (Okuda and Ito, 2011).
Moreover, its tyrosinase inhibition properties have been largely at-
tributed to their competitive inhibition of monophenolase and strong
copper chelation activity (Niu and Aisa, 2017).
3.2. Antioxidant activity
Free radicals and other oxidants have played central role in the
pathophysiology of various diseases through several mechanisms, being
lipid peroxidation one of the most extensively used research model for
identification of natural antioxidants (Lü et al., 2010). This process is
initiated when any free radical attacks and abstracts a reactive hy-
drogen atom from a methylene group in an unsaturated fatty acid,
which results in the formation of a carbon-centred lipid radical. The
lipid radical can then react with molecular oxygen to form a lipid
peroxyl radical that later undergoes rearrangement to form mal-
ondialdehyde (MDA) and 4-hydroxynonenal (4-HNA) (Phaniendra
et al., 2015). These toxic end-products cause damage to DNA, mem-
brane proteins, enzymes, and receptors, among others, which can lead
to cell lysis or exacerbate the activity of various cascades implicated in
degenerative diseases and cancer (Phaniendra et al., 2015). Lipid per-
oxyl radicals can also further propagate the peroxidation process by
abstracting hydrogen atoms from the other lipid molecules. In a dose-
dependent manner, both methods, OxHLIA and TBARS, allowed the
evaluation of the antioxidant effect of the studied hydroethanolic ex-
tracts (CH, PCH, SCH, and NCH) and; although through different me-
chanisms, both are equally a consequence of lipid peroxidation.
OxHLIA establishes the time and concentration at which antioxidants
can retard haemolysis by capturing the hydrophilic and/or lipophilic
radicals, and TBARS the concentration at which the extracts can pre-
vent the formation of MDA through the donation of hydrogen atoms to
the lipid peroxyl radical species. The obtained results for both assays
are displayed in Table 3. All the four tested extracts showed high
bioactivity, on the order of nanograms per millilitre, and lower IC50
than the tested positive control, trolox, a water-soluble analogue of
vitamin E. Concerning OxHLIA assay, all the IC50 values of the tested
extracts were approximately 30 up to 73 times lower, and for TBARS
approximately 9 up to 16 times inferior to trolox. The lowest IC50, for
both assays, was obtained by the petals extract (OxHLIA: 279 ng/mL
(Δt = 60 min) and 384 ng/mL (Δt = 120 min); TBARS: 342 ng/mL).
There is certain agreement that complete based hydrogen atoms
transfer assays (HAT) include among others, 1,1-diphenyl-2-picrylhy-
drazyl radical (DPPH*) and OxHLIA assays. In a 2019 study performed
by Maisetta and colleagues, C. hypocistis whole plant ethanolic extracts
displayed strong antioxidant activity, DPPH: 6.8 ± 1.2 μg/mL
Table 2
Phenolic compounds quantification in C. hypocistis extracts.
Peak Tentative identification Content (mg/g extract)
CH PCH SCH NCH
1 Galloyl-glucose1 0.81 ± 0.01c 1.9 ± 0.05a 1.19 ± 0.08b 0.77 ± 0.05c
2 Digalloyl-glucose1 0.99 ± 0.01b 1.68 ± 0.03a 0.335 ± 0.004d 0.65 ± 0.02c
3 Trigalloyl-glucose1 1.47 ± 0.04a 0.46 ± 0.04b 1.49 ± 0.07a 0.146 ± 0.003c
4 (+)-Catechin2 1.83 ± 0.04c 2.9 ± 0.1a 2.17 ± 0.06b 1.69 ± 0.03d
5 Trigalloyl-glucose1 1.09 ± 0.03b 1.41 ± 0.06a 0.64 ± 0.03c tr
6 Trigalloyl-HHDP-glucose1 1.26 ± 0.04c 1.88 ± 0.03b 2.52 ± 0.08a 0.29 ± 0.01d
7 Tetragalloyl-glucoside1 1.907 ± 0.004b 1.13 ± 0.02c 2.7 ± 0.1a 0.114 ± 0.005d
8 Pedunculagin (bis-HHDP-glucose)3 2.23 ± 0.03b 3.34 ± 0.05a 1.63 ± 0.04c tr
9 Pentagalloyl-glucose1 5.10 ± 0.04a 5.3 ± 0.2a 3.7 ± 0.2b 1.43 ± 0.06c
10 Galloyl-bis-HHDP-glucose3 42 ± 1a 41 ± 1a 34 ± 1b 5.43 ± 0.05c
11 Pentagalloyl-glucose1 0.85 ± 0.03b 2.80 ± 0.01a 0.14 ± 0.01c 0.114 ± 0.004c
12 Galloyl-bis-HHDP-glucose3 9.60 ± 0.05b 11.1 ± 0.3a 6.8 ± 0.3c 2.1 ± 0.1d
13 Digalloyl-bis-HHDP-glucos3 6.45 ± 0.01a 6.5 ± 0.2a 5.1 ± 0.1b 1.74 ± 0.02c
14 Digalloyl-bis-HHDP-glucose 3 18.3 ± 0.4b 27.2 ± 0.1a 11.4 ± 0.2c 3.64 ± 0.02d
15 Digalloyl-bis-HHDP-glucose3 5.4 ± 0.1b 7.7 ± 0.1a 1.65 ± 0.02c 1.78 ± 0.02c
16 Trigalloyl-bis-HHDP-glucose3 2.58 ± 0.02c 13.1 ± 0.7a 4.2 ± 0.1b 1.30 ± 0.01d
17 Trigalloyl-bis-HHDP-glucose3 nd 7.4 ± 0.3* 2.35 ± 0.01* nd
Σ Phenolic compounds 102.0 ± 0.6b 137 ± 2a 82 ± 2c 21.2 ± 0.2d
CH: whole plant extract; PCH: petals extract; SCH: stalks extract; NCH: nectar extract. Standard calibration curves recorded at 280 nm: (1)- Gallic acid
(y = 131538x + 292163; R2 = 0.9998; LOD = 0.68 μg/mL; LOQ = 1.61 μg/mL); (2)- catechin (y = 84950x + 23200; R2 = 0.9999; LOD = 0.17 μg/mL;
LOQ = 0.68 μg/mL); (3)- Ellagic acid (y = 26719x - 317255; R2 = 0.9996; LOD = 0.10 μg/mL; LOQ = 0.48 μg/mL). In each row, different letters correspond to
significant differences (p < 0.05) between samples. *Means statistical differences obtained by a t-student test.
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(Maisetta et al., 2019). Although both studies utilised HAT in vitro
methods, the present study assay considered the level of oxidative stress
in a biological sample, with biological fluids and cell components
present during the analysis. Despite these potential external inter-
ferences, when compared, the ability of CH extracts to quench free
radicals by hydrogen donation was higher for the present study, 24-fold
more effective.
3.3. Antibacterial activity
In recent years, antibiotic resistance has become an alarming issue,
which increased the interest on plant-derived compounds discovery as
new active antibacterial agents (Stojković et al., 2013). The four hy-
droethanolic extracts (CH, PCH, SCH and NCH) of C. hypocistis were
evaluated for their antibacterial potential against multi-resistant pa-
thogenic strains (Table 4), such as Gram-positive (E. feacalis, L. mono-
cytogenes, and MRSA) and Gram-negative bacteria (E. coli, P. mirabilis,
K. pneumoniae, P. aeruginosa, and M. morganii). Ampicillin is a beta-
lactamic antibiotic widely used for its ability to destroy Gram-positive
and Gram-negative bacteria (Rozas et al., 2010). Compared to this
antibiotic, all the four C. hypocistis tested extracts were more effective
against three Gram-negative bacteria. Considering K. pneumoniae, the
extracts were 2 to 8-fold more effective than ampicillin. For P. aerugi-
nosa and M. morganii, 8 to 16-fold more effective than ampicillin. MBC
values were not obtained for any of the tested extracts (values >
20 mg/mL). The MIC values shown in Table 4 indicate that the extracts
were active against both Gram-negative and Gram-positive bacteria,
being the first more sensitive to all the plant extracts. In general, the
hydroethanolic extracts from the stalks were the most (SCH
MIC = 0.625–2.5 mg/mL) and the nectar the least (NCH
MIC = 2.5–10 mg/mL) effective to inhibit both Gram-positive and
Gram-negative bacteria growth. For three tested microorganisms
(MRSA, K. pneumoniae, and P. aeruginosa), C. hypocistis ethanolic ex-
tracts displayed better MICs in a recent study (Maisetta et al., 2019).
This could be due to the use of clinical isolates in the present study,
which might exhibit a higher resistance profile when compared with
the ATCC strains tested by Maisetta and co-workers. Although both
studies tested the capacity of the extracts to inhibit bacterial growth,
the plant material from the other study was previously resuspended in
cyclohexane, the collected supernatant lyophilised, and later subjected
to a second extraction with ethanol. The pre-extraction step reported by
Maisetta et al. (2019) might also be accountable for the obtained MIC
values due to a higher concentration of extracted polar compounds
(Maisetta et al., 2019). Previous studies investigating the antimicrobial
activity of tannin-rich plant extracts have attributed the microbial
growth inhibition to their content in gallotannins and related com-
pounds, which mainly act on the membranes of the bacteria and/or
their ability to complex metal ions (Maisetta et al., 2019). Several
studies have also shown that Gram-negative bacteria are more resistant
to plant derived biomolecules due to the strong repulsive negative
charge of its lipopolysaccharides (Maisetta et al., 2019). Contrarily, in
the present work, the extracts were more effective inhibiting Gram-
negative bacteria, and as such, the studied extract could become a
source to the discovery of novel antimicrobial agents.
3.4. Antidiabetic activity
α-Glucosidase inhibitors fall under the third category of oral hy-
poglycemic agents. They cleave glyosidic bonds in complex carbohy-
drates to release absorbable monosaccharides; thus, α-glucosidase in-
hibitors display useful anti-hyperglycaemic effects and can be an
important strategy in the management of hyperglycaemia linked to type
2 diabetes (Leroux-Stewart et al., 2015). Only a few α-glucosidase in-
hibitors are commercially available, and all of them involve tedious
multi-step procedures. Additionally, clinically they have been asso-
ciated with serious gastrointestinal side effects (Leroux-Stewart et al.,
2015). Therefore, the discovery of potent non-sugar based α-glucosi-
dase inhibitors from natural sources have been receiving tremendous
attention, due to the highly abundant compounds in nature and their
promising biological activities (Yin et al., 2014). The α-glucosidase
inhibitor effectiveness of the different extracts (Table 5) was expressed
on the basis of resulting IC50 values. SCH was the best extract
(0.039 mg/mL), followed by CH (0.040 mg/mL), PCH (0.046 mg/mL),
and NCH (0.214 mg/mL). The SCH IC50 was approximately 21 times
lower than the positive control acarbose. For PCH and CH, the IC50
values were approximately 20 and 18 times lower, respectively. The
Table 3
Antioxidant activity of C. hypocistis extracts and positive control measured by
the cell-based assays of OxHLIA and TBARS.
OxHLIA (IC50, ng/mL) TBARS (IC50, ng/mL)
Δt = 60 min Δt = 120 min
CH 285 ± 4b,c 406 ± 5c 413 ± 9c
PCH 279 ± 5c,d 384 ± 9c 342 ± 2d
SCH 306 ± 2b 458 ± 4b 634 ± 12a
NCH 672 ± 15a 1032 ± 28a 551 ± 13b
Trolox* 20384 ± 363 44212 ± 1500 5389 ± 320
CH: whole plant extract; PCH: petals extract; SCH: stalks extract; NCH: nectar
extract. The results are presented as mean ± standard deviation and expressed
as IC50 values, which correspond to the extract concentration in ng/mL required
to protect 50% of the erythrocyte population from haemolysis for Δt of 60 min
and 120 min or to provide 50% of antioxidant activity in the OxHLIA and
TBARS assays, respectively. In each column, different letters correspond to
significant differences (p < 0.05) between samples. *Trolox differs sig-
nificantly from the plant extracts (p < 0.05).
Table 4
Antibacterial activity of C. hypocistis extracts and positive controls.
CH PCH SCH NCH Ampicillin Imipenem Vancomycin
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Gram-negative bacteria
Escherichia coli 1.25 > 20 1.25 >20 0.625 >20 2.5 > 20 <0.15 < 0.15 < 0.0078 <0.0078 n.t. n.t.
Klebsiella pneumoniae 1.25 > 20 1.25 >20 1.25 > 20 5 >20 10 20 <0.0078 <0.0078 n.t. n.t.
Morganella morganii 1.25 > 20 2.5 >20 1.25 > 20 2.5 20 20 >20 <0.0078 <0.0078 n.t. n.t.
Proteus mirabilis 1.25 20 1.25 20 1.25 20 5 >20 <015 <0.15 < 0.0078 <0.0078 n.t. n.t.
Pseudomonas aeruginosa 2.5 > 20 2.5 >20 1.25 > 20 2.5 > 20 >20 >20 0.5 1 n.t. n.t.
Gram-positive bacteria
Enterococcus faecalis 2.5 20 2.5 >20 2.5 > 20 5 >20 <0.15 < 0.15 n.t. n.t. < 0.0078 <0.0078
Listeria monocytogenes 2.5 > 20 2.5 >20 2.5 > 20 10 >20 <0.15 < 0.15 < 0.0078 <0.0078 n.t. n.t.
MRSA 1.25 > 20 1.25 >20 0.625 >20 2.5 > 20 <0.15 < 0.15 n.t. n.t. 0.25 0.5
CH: whole plant extract; PCH: petals extract; SCH: stalks extract; NCH: nectar extract; n.t.: not tested; MRSA: Methicillin Resistant Staphylococcus aureus; MIC:
Minimum inhibitory concentration in mg/mL; MBC: Minimum bactericidal concentration in mg/mL.
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nectar extract presented a biggest IC50 value, approximately 2.6 times
higher than acarbose. To the authors’ best knowledge, this is the first
report evaluating the anti-α-glucosidase activity of C. hypocistis ex-
tracts; therefore, no comparisons could be performed.
3.5. Anti-tyrosinase activity
Tyrosinase is widely distributed in microorganisms, animals, and
plants. This binuclear copper centre enzyme catalyses two distinct re-
actions: the hydroxylation of tyrosine by monophenolase action and the
oxidation of 3,4-dihydroxyphenylalanine (L-DOPA) to o-dopaquinone
through diphenolase action. Sequentially, dopaquinone can be readily
converted to dopachrome, an orange to red pigment (Kim and Uyama,
2005). Tyrosinase catalyses the oxidation of phenolic compounds to the
corresponding quinones and is responsible for the enzymatic browning
of fruits and vegetables, which display a characteristic undesirable
colour and flavour. The oxidation products of phenolic compounds can
then react with other food components, including amines, peptides, and
proteins, which further reduces food quality and digestibility (Shao
et al., 2018). Tyrosinase also plays a critical role in the biosynthesis of
melanin and its over-activity can cause skin hyperpigmentation (Niu
and Aisa, 2017). Products containing ingredients such as hydroquinone,
kojic acid, and retinoids have been utilised in the past to suppress the
severity of hyperpigmentation; however, long term exposure to them
have been reported to present cytotoxic, irritating, and mutagenic ef-
fects on the skin (Draelos, 2007). Therefore, the discovery of novel
high-performance tyrosinase inhibitors is in great need for the food and
cosmetic field.
Tyrosinase inhibition was determined using purified enzyme from
mushroom and expressed on the basis of resulting IC50 values presented
on Table 5. To the authors’ best knowledge, this is the second study
reporting a quantitative analysis of C. hypocistis anti-tyrosinase activity
(Maisetta et al., 2019). Although to different extents, all C. hypocistis
ethanolic extracts were able to inhibit tyrosinase activity, being the
stalks the best result (SCH: 0.09 mg/mL), followed by the petals (PCH:
0.19 mg/mL), whole plant (CH: 0.20 mg/mL), and nectar (NCH:
27.6%). For the maximum tested concentration (0.5 mg/mL), NCH was
only able to inhibit 27.6% of tyrosinase. SCH was the extract exhibiting
the closest IC50 (0.09 mg/mL) value comparing to the positive control,
kojic acid (0.078 mg/mL), one of the most intensively studied
tyrosinase inhibitors (Draelos, 2007). C. hypocistis whole plant dis-
played a better IC50 (0.0098 mg/mL) in a 2019 study (Maisetta et al.,
2019). Similarly, to the antibacterial activity, this could be due to the
pre-extraction step performed by Maisetta and colleagues and there-
fore, the presence of a higher concentration of bioactive compounds.
3.6. Anti-proliferative and hepatotoxic activity
Plant-derived products garner increasing attention in cancer che-
motherapy, aside from view as more biologically friendly, and conse-
quently more co-evolved with their target sites, there is also evidence
that natural product-derived anticancer drugs have alternative modes
of promoting cell death (Gali-Muhtasib et al., 2015; Khalid et al., 2016).
C. hypocistis hydroethanolic extracts were screened for their cytotoxic
activity using different tumour cell lines. The sulforhodamine B col-
orimetric assay was applied in order to determine the inhibitory growth
activity of the tested extracts for four human tumour cell lines:
NCI–H460 (non-small cell lung cancer), HeLa (cervical carcinoma),
HepG2 (hepatocellular carcinoma), and MCF-7 (breast carcinoma). The
results (Table 5) are expressed as GI50, which represents the C. hypo-
cistis extracts concentrations required to inhibit 50% of cell growth. The
values were in general lower (high activity), showing a significant dose-
dependent cytotoxic effect. In absolute terms, the cell line HepG2 was
the most susceptible to C. hypocistis extracts, followed by HeLa,
NCI–H460, and MCF-7. HeLa (GI50 = 68 μg/mL) was the most vul-
nerable cell line to C. hypocistis extracts action, namely SCH. C. hypo-
cistis nectar (NCH) showed the least effective results. When comparing
its GI50, the values were 1.44–2.35-fold higher than the optimal value
for the different tested cell lines: HeLa (NCH: 159 μg/mL versus SCH:
68 μg/mL), NCI–H46 (NCH: 175 μg/mL versus PCH: 93 μg/mL), MCF-7
(NCH: 206 μg/mL versus SCH: 98 μg/mL), and HepG2 (NCH: 110 μg/
mL versus SCH: 77 μg/mL). From all the four C. hypocistis extracts
tested (CH, PCH, SCH and NCH), the stalks extract (SCH) exhibited the
best GI50 values for three cell lines (HeLa, MCF-7, and HepG2). Al-
though the petals extract (PCH) presented a better GI50 for one of the
tested cell lines, NCI–H460, the value was really similar when com-
pared with SCH, 93 μg/mL versus 100 μg/mL.
To the authors’ best knowledge, there are only two studies on the
cytotoxic activity of C. hypocistis extracts (Magiatis et al., 2001; Zucca
et al., 2015). The data from the present study are in accordance with
Table 5
Enzyme inhibitory, anti-proliferative, hepatotoxic, and anti-inflammatory properties of C. hypocistis extracts and positive controls.
CH PCH SCH NCH Positive control
Antidiabetic activity (IC50, mg/mL) Acarbose
α-Glucosidase 0.040 ± 0.001c 0.046 ± 0.004c 0.039 ± 0.001c 0.214 ± 0.005b 0.83 ± 0.02a
Tyrosinase inhibition activity (IC50, mg/mL) Kojic acid
Tyrosinase 0.20 ± 0.01a 0.19 ± 0.01b 0.09 ± 0.02c 27.6 ± 0.7%* 0.078 ± 0.001d
Cytotoxic activity (GI50, μg/mL) Ellipticine**
HeLa 80 ± 7b 71 ± 2b 68 ± 4b 159 ± 5a 1.91 ± 0.06
NCI–H460 102 ± 4b 93 ± 8b 100 ± 6b 175 ± 13a 1.03 ± 0.09
MCF-7 117 ± 6b 103 ± 7b 98 ± 4b 206 ± 11a 1.1 ± 0.2
HepG2 80 ± 2b,c 90 ± 6b 77 ± 2c 110 ± 3a 1.1 ± 0.2
PLP2 >400 >400 >400 >400 3.2 ± 0.7
Anti-inflammatory activity (IC50, μg/mL) Dexamethasone**
RAW 264.7 136 ± 11b 127 ± 8c 127 ± 12c 277 ± 14a 16 ± 1
CH: whole plant extract; PCH: petals extract; SCH: stalks extract; NCH: nectar extract. The results are presented as mean ± standard deviation and expressed as IC50
(extract concentration in mg/mL responsible for 50% enzyme inhibition), GI50 (extract concentration in μg/mL responsible for 50% of growth inhibition in human
tumour cell lines and a liver primary cell culture) or IC50 (extract concentration in μg/mL responsible for 50% inhibition in NO production) values. *Result given as
percentage inhibition at 0.5 mg/mL. In each row, different letters correspond to significant differences (p < 0.05) between samples. **The positive control differs
significantly from the plant extracts (p < 0.05).
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that reported by Magiatis and colleagues, who found that the metha-
nolic extracts of three Greek Cytinus taxa exhibited cytotoxic activity
against several cancer cell lines (Magiatis et al., 2001). These results led
the authors to the fractionation of the methanolic extracts by medium
pressure liquid chromatography (MPLC), obtaining an inactive fraction
(GI50 > 400), containing mainly sugars, and a fraction with increased
cytotoxicity when compared to the total methanolic extracts. For the
two species of C. hypocistis studied by Magiatis and co-workers, me-
thanolic extracts exhibited GI50 of 100 and 98 μg/mL for human
mammary adenocarcinoma (MDA-MB-231), in contrast with GI50 of 75
and 77 μg/mL for the cytotoxic active fraction. Similar results were
obtained for human bladder transitional cell carcinoma (BC3c), 110
and 105 μg/mL, in contrast with 71 and 67 μg/mL for the active frac-
tion (Magiatis et al., 2001). The authors attributed this cytotoxic ac-
tivity to hydrolysable tannins, without any obvious dependence on their
molecular weights. Although in the present work different cell lines
were used, both studies exhibited a similar range of GI50 regarding total
extracts analysis. Because porcine hepatocytes are close to human he-
patocytes in terms of metabolism and ammonia elimination, the four C.
hypocistis extracts were tested for their hepatotoxic activity on non-tu-
mour porcine liver cells (PLP2) (Table 5), and up to the maximal tested
concentration (400 μg/mL) no toxicity was observed (Shi et al., 2016).
3.7. Anti-inflammatory activity
Macrophages play an essential role in the anti-inflammatory process
and can be activated by interferon gamma (IFN-γ), interleukins (IL-4,
IL-10, IL-13), transforming growth factor beta (TGF-β), and some
structures from pathogenic microorganisms such as lipopolysaccharides
(LPS) (Pohanka et al., 2011). During pathogen invasion, immunocytes
secrete inflammatory mediators, such as nitric oxide (NO) and pros-
taglandin E2 (PGE2), via the inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2). iNOS and COX-2 are involved in tumour
progression through various mechanisms, including inhibition of
apoptosis, stimulation of angiogenesis and promotion of tumour cell
proliferation (Guo et al., 2014). All the four C. hypocistis extracts suc-
cessfully reduced the expression of the anti-inflammatory enzyme iNOS,
in LPS-activated murine macrophages. NO reduction was measured
employing a Griess reagent system kit and expressed as lower IC50
values (Table 5). Among all extracts, the petals extract (PCH) showed
the highest inhibitory effects in NO production by LPS-stimulated
RAW264.7 cells (IC50 = 127 μg/mL), followed by SCH (IC50 = 127 μg/
mL), CH (IC50 = 136 μg/mL), and NCH (IC50 = 277 μg/mL). To the
authors’ best knowledge, this is novel study regarding the anti-in-
flammatory activity of C. hypocistis and thus no comparisons could be
performed.
4. Conclusion
In this study, the chemical fingerprint of Cytinus hypocistis (L.) L.
hydroethanolic extracts was determined and its antioxidant, anti-
bacterial, antidiabetic, anti-tyrosinase, anti-proliferative, hepatotoxic,
and anti-inflammatory properties evaluated. A total of 17 phenolic
compounds were identified, being galloyl-bis-HHDP-glucose, digalloyl-
bis-HHDP-glucopyranose, and trigalloyl-bis-HHDP-glucose the most
abundant. In absolute terms, SCH was the extract exhibiting higher
antibacterial, antidiabetic, anti-tyrosinase, and anti-proliferative ac-
tivity, followed by the PCH extract. Regarding the anti-inflammatory
and antioxidant properties, PCH exhibited the best results. Although for
the four studied samples the 17 identified phenolic compounds were the
same, its concentration was higher in the petals extract, followed by the
stalks, being these the two parts of C. hypocistis unveiling the strongest
colours. These results point a potential correlation between the phe-
nolic profile of C. hypocistis and its properties. All these bioactive ef-
fects, with no evidence of cytotoxicity in a non-tumour cell line, could
make this plant ideal to be explored for the development of herbal
formulations and bio-based ingredients. For its bioactivity validation
and mechanism investigation, further studies on fractionation, isolation
and characterization of compounds of the extracts of C. hypocistis are
currently under way.
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